Sign in

CIK 0001746466 · Non-accelerated filer<br>Smaller reporting company

Equillium, Inc.

Sign in to watch
Ticker
EQ
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
821554746
Phone
(858) 412-5302
Business address
2223 AVENIDA DE LA PLAYA, SUITE 105, LA JOLLA, CA, 92037
  1. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  2. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  3. 8-K Event Unregistered share sale · Regulation FD disclosure · Other events
  4. 8-K Event Other events
  5. 10-Q Report Quarterly Report
  6. SCHEDULE 13G Stake Statement of Beneficial Ownership
  7. 8-K Event Results of operations
  8. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  9. 144 Insider Sale of Securities
  10. 4 Planned sale Sr. Vice President and COO sold 14,584 shares at $2.93 ($42,737)
  11. 4 Open-market sale President and CSO sold 230,975 shares at an average $3.13 ($723,830)
  12. 144 Insider Sale of Securities
  13. 4 Planned sale Principal Accounting Officer sold 65,000 shares at $2.95 ($191,750)
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Planned sale Sr. Vice President and COO sold 95,833 shares at an average $2.79 ($267,209)
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 8-K Event Shareholder vote results

Page 1 of 24 · 466 filings